1-3 of 3
Jiangao Zhu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD27-Armored BCMA-CAR T Cell (CBG-002) Therapy for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial

Yang Xu, Xuzhao Zhang, Dijia Xin, Jiawei Zhang, Luyao Wang, Yili Fan, Boxiao Chen, Wen Lei, Xi Qiu, Huawei Jiang, Xibin Xiao, Liansheng Huang, Wenjun Yang, Jiangao Zhu, Wenbin Qian
Journal: Blood
Blood (2023) 142 (Supplement 1): 3468.
https://doi.org/10.1182/blood-2023-174364
Published: 2023
Journal Articles

Induction of type I IFN is required for overcoming tumor-specific T-cell tolerance after stem cell transplantation

Ian Horkheimer, Michael Quigley, Jiangao Zhu, Xiaopei Huang, Nelson J. Chao, Yiping Yang
Journal: Blood
Blood (2009) 113 (21): 5330–5339.
https://doi.org/10.1182/blood-2008-05-155150
Published: 2009
Journal Articles

Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-β

Jiangao Zhu, Jennifer Martinez, Xiaopei Huang, Yiping Yang
Journal: Blood
Blood (2006) 109 (2): 619–625.
https://doi.org/10.1182/blood-2006-06-027136
Published: 2006
Includes: Supplemental data